OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes Affects Antibody Response to SARS-CoV-2 Vaccination in Older Residents of Long-term Care Facilities: Data From the GeroCovid Vax Study
Enrico Virgilio, Caterina Trevisan, Angela Marie Abbatecola, et al.
Diabetes Care (2022) Vol. 45, Iss. 12, pp. 2935-2942
Open Access | Times Cited: 20

Showing 20 citing articles:

Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review
Yanfei He, Jing Ouyang, Xiao Hu, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 6, pp. 892-918
Open Access | Times Cited: 18

Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study
Caterina Trevisan, Valeria Raparelli, Alba Malara, et al.
Internal and Emergency Medicine (2023) Vol. 18, Iss. 5, pp. 1337-1347
Open Access | Times Cited: 11

Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis
Chiara Bellia, Aikaterini Andreadi, Ilenia D’Ippolito, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 11

COVID-19 vaccines and blood glucose control: Friend or foe?
Walter Vena, Stella Pigni, Nazarena Betella, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2

Molecular Mechanisms Responsible for Diabetogenic Effects of COVID-19 Infection—Induction of Autoimmune Dysregulation and Metabolic Disturbances
Barbara Grubišić, Luka Švitek, Klara Ormanac, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11576-11576
Open Access | Times Cited: 7

COVID-19 vaccine updates for people under different conditions
Yi-Jiao Huang, Weiyang Wang, Yan Liu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 11, pp. 2323-2343
Closed Access | Times Cited: 1

Type 2 diabetes and Covid-19: Lessons learnt, unanswered questions and hints for the future
P. Nazari, Paolo Pozzilli
Diabetes Research and Clinical Practice (2023) Vol. 204, pp. 110896-110896
Closed Access | Times Cited: 4

Factors Affecting SARS-CoV-2 IgG Production after Vaccination and/or Disease: A Large-Scale Seroprevalence Study
Tanja Karl, Anja Schuster, Lea Maria Stangassinger, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1615-1615
Open Access | Times Cited: 4

Evaluation of Antibody Response and Adverse Effects following Heterologous COVID-19 Vaccine Booster with mRNA Vaccine among Healthcare Workers in Indonesia
Gatot Soegiarto, Bagus Aulia Mahdi, Laksmi Wulandari, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1160-1160
Open Access | Times Cited: 3

Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: The GeroCovid Vax Study
Caterina Trevisan, Labjona Haxhiaj, Alba Malara, et al.
Drugs & Aging (2023) Vol. 40, Iss. 12, pp. 1133-1141
Closed Access | Times Cited: 2

Unveiling therapeutic dynamics: An in-depth comparative analysis of neutralizing monoclonal antibodies and favipiravir in alleviating COVID-19 outpatients impacts among middle-aged and special populations (MA-FAST)
Taweegrit Siripongboonsitti, Kriangkrai Tawinprai, Thachanun Porntharukcharoen, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 7, pp. 102471-102471
Open Access

Efecto de la exposición previa a COVID-19, ocurrencia de brotes y tipo de vacuna en la respuesta inmune humoral de adultos mayores institucionalizados
María Fernanda Aguirre, María Jimena Marro, Pamela Elizabeth Rodríguez, et al.
Cadernos de Saúde Pública (2024) Vol. 40, Iss. 9
Open Access

Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 Omicron subvariant during pregnancy - A case series study
Marie Didembourg, Clara David, Laure Morimont, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41249-e41249
Open Access

Risk of breakthrough SARS‐CoV‐2 infection and clinical outcomes among vaccinated patients with type 2 diabetes
Sungho Bea, Ahhyung Choi, Jae Hyeon Kim, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2734-2742
Closed Access | Times Cited: 1

Promoting and Building Long-Term Care Health Research Networks: GeroCovid Observational and Gerocovid Vax Initiatives
Angela Marie Abbatecola, Raffaele Antonelli Incalzi, Giuseppe Bellelli, et al.
Journal of the American Medical Directors Association (2023) Vol. 24, Iss. 6, pp. 926-927.e2
Closed Access

Association of selenium profile with neutralizing antibody response to inactivated SARS-CoV-2 vaccination
Sikang Gao, Na Ren, Taoping Sun, et al.
Journal of Trace Elements in Medicine and Biology (2023) Vol. 80, pp. 127295-127295
Closed Access

Monovalent SARS-CoV-2 mRNA Vaccine Does not Boost Omicron-Specific Immune Response in Diabetic and Control Pediatric Patients
Alan Sariol, Molly A. Vickers, Shannon M Christensen, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 4, pp. 1059-1067
Open Access

Humoral response after breakthrough SARS-CoV-2 infection in type 2 diabetes mellitus patients
Aleksander Michalski, Magdalena Góralczyk, Michał Brzozowski, et al.
Current Issues in Pharmacy and Medical Sciences (2023) Vol. 36, Iss. 4, pp. 221-226
Open Access

Page 1

Scroll to top